NCT01674985

Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences · Academic / Other
• Sex: All
• Age: 10 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate whether infusion of G-CSF mobilized HLA-mismatched peripheral blood stem cells (G-PBSC) combining decitabine and cytarabine chemotherapy can improve outcomes in myelodysplastic syndromes (MDS) patients.

Conditions

• Myelodysplastic Syndromes

Interventions

Type	Name	Description
BIOLOGICAL	Microtransplantation	Infusion of G-CSF mobilized HLA-mismatched peripheral blood stem cells (G-PBSC)

Timeline

• Start date: 2009-09-01
• Primary completion: 2013-10-01
• Completion: 2015-12-01
• First posted: 2012-08-29
• Last updated: 2016-07-13

Locations

1 site across 1 country: China